Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...

B-cell therapy uses drugs called monoclonal antibodies to attack white blood cells known as B cells that cause nerve damage. The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus)treats ...

PPMS is a less common form of MS characterized by a gradual worsening of symptoms from the onset, whereas RRMS involves distinct relapses followed by periods of remission. PPMS is typically diagnosed ...

Multiple sclerosis (MS) is an autoimmune condition in which the protective insulation surrounding neurons in the brain and spinal cord is erroneously attacked. This can cause a wide variety of serious ...

Medicare Parts A and B, Medicare Advantage (Part C), and Medicare Part D offer various levels of coverage for the costs associated with multiple sclerosis (MS) care, including different types of drugs ...